Most Recent
ASIC won’t eavesdrop on ex-Rio Tinto execs’ US depositions
Securities December 12, 2018 12:43 pm By Cat Fredenburgh

The Australian Securities and Investments Commission has promised it will stay away from the depositions of two former Rio Tinto executives in proceedings underway in […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Commonwealth slams Otsuka’s ‘inconsistent’ defences in Abilify patent case
Intellectual Property December 10, 2018 10:02 pm By Miklos Bolza

The Commonwealth has urged the court to strike out the “inconsistent” pleadings of pharmaceutical firms Otsuka and Bristol-Myers Squibb in a patent case over the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Quinn’s fees, funder’s cut slashed in Bank of Queensland class action settlement
Class Actions November 26, 2018 10:47 pm By Cat Fredenburgh

A judge has taken a hatchet to Quinn Emanuel’s fees and the funder’s cut in a $12 million settlement of a class action against Bank […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Ex-CFO said Rio Tinto reserve write down would be ‘worse by far than expected’, ASIC claims
Corporate November 13, 2018 11:21 pm By Cat Fredenburgh

The Australian Securities and Investments Commission claims Rio Tinto’s former CFO was referring to the write down for the reserves for two coal assets that […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Bank of Queensland loses fight with insurer over $6M class action settlement
Insurance November 7, 2018 10:22 pm By Cat Fredenburgh

Bank of Queensland has lost a dispute with two insurers over coverage for a $6 million settlement of a class action brought by investors in […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Alphapharm slams Sanofi amendment delay in injunction battle
Intellectual Property November 2, 2018 10:09 pm By Miklos Bolza

Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Alphapharm loses bid for docs in Sanofi injector pen patent dispute
Intellectual Property October 30, 2018 11:47 pm By Cat Fredenburgh

Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Federal Court to weigh in on genome editing patent
Intellectual Property October 17, 2018 3:22 pm By Cat Fredenburgh

A South Korean biotech company has filed an appeal with the Federal Court after an Ashurst partner succeeded in opposing the company’s proposed patent for […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Crown says NSW gov’t ‘spruiked’ to block Sydney harbour views
Real Estate October 15, 2018 11:25 pm By Miklos Bolza

Crown Resorts has accused the NSW government of breaching its contractual obligations by “spruiking” to construction firms for development at central Barangaroo that would obstruct its […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.
Genome editing patent gets thumbs down by IP Australia
Intellectual Property September 19, 2018 8:58 pm By Miklos Bolza

A patent for genome editing technology by a South Korean biotechnology company has been rejected for a lack of clarity, novelty, and inventiveness, but the […]

Subscribe for instant access to all Lawyerly content. Already a subscriber? Login here. Want to test drive Lawyerly? Contact us to take a free trial.